Pyrimethamine is an antiparasitic drug which inhibits tumor growth and metastasis in pulmonary carcinoma by attacking the dihydrofolate reductase (DHFR) and thymidine phosphorylase (TP) [96, 97]. Here, DHFR is linked to neoplasm.